Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 11, Number 4—April 2005


Childhood Hemolytic Uremic Syndrome, United Kingdom and Ireland

Richard M. Lynn*, Sarah J. O’Brien†1Comments to Author , C. Mark Taylor‡, Goutam K. Adak†, Henrik Chart§, Tom Cheasty§, John E. Coia¶, Iain A. Gillespie†, Mary E. Locking#, William J. Reilly#, Henry R. Smith§, Aoife Waters**, and Geraldine A. Willshaw§
Author affiliations: *Royal College of Paediatrics and Child Health, London, United Kingdom; †Communicable Disease Surveillance Centre, London, United Kingdom; ‡Birmingham Children’s Hospital, Birmingham, United Kingdom; §Health Protection Agency Centre for Infections, London, United Kingdom; ¶Western General Hospital, Edinburgh, United Kingdom; #Scottish Centre for Infection and Environmental Health, Glasgow, United Kingdom; and; **The Children’s Hospital, Dublin, Ireland

Main Article

Table 2

Clinical features and acute complications of diarrhea-associated hemolytic uremic syndrome (HUS) in children from the 1997–2001 British Paediatric Surveillance Unit survey compared with children from the 1985–1988 survey

1985–1988 survey 1997–2001 survey p value
No. of cases 288 413
Cases with a diarrheal prodrome 273 (95%) 395 (96%) 0.6
Mean (range) time from onset of diarrhea to diagnosis of HUS 8 days (1–34) 6 days (range 1–35) <0.001
Severe acute abdominal symptoms 40 (15%) 36 (9%) 0.03
Seizures or other neurologic complications 51(19%) 52 (13%) 0.06
Hypertension 86 (32%) 92 (23%) 0.02
Cardiomyopathy 4 (1%) 7 (2%) 1.0
Diabetes mellitus 4 (1%) 8 (2%) 0.77

Main Article

1Current affiliation: University of Manchester, Salford, United Kingdom

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO